Agilent Technologies A
NYSE A
$157.37 +2.29 (+1.47%)
As of: Aug 27, 2026 · 3:59 PM EDT

Agilent Technologies (A) Cash from Financing Activities (2009 - 2026)

Agilent Technologies (A) posted quarterly Cash from Financing Activities of -$144.0 million for Q2 2026, down 24.14% year-over-year from -$189.8 million in Q2 2025, and up 35.14% quarter-over-quarter from -$222.0 million in Q1 2026.

Agilent Technologies (A) Cash from Financing Activities (2009 - 2026) Analysis & Trends

Agilent Technologies (A) has reported Cash from Financing Activities for 18 consecutive years, with -$144.0 million the latest figure, recorded in Q2 2026.

  • In Q2 2026, Cash from Financing Activities fell 24.14% year-over-year to -$144.0 million; the TTM figure through Apr 2026 stood at -$785.0 million (down 51.84% YoY), while the FY2025 annual figure was -$715.0 million, up 4.92% from the prior year.
  • Cash from Financing Activities climbed to -$144.0 million in Q2 2026 per A's latest filing, from -$222.0 million in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $25.0 million in Q4 2024 and bottomed at -$546.0 million in Q1 2022.
  • Historically, Cash from Financing Activities has averaged -$229.7 million across 5 years, with a median of -$220.5 million in 2025.
  • On a YoY basis, Cash from Financing Activities climbed as much as 112.44% in 2024 and fell as far as 1311.76% in 2024.
  • Agilent Technologies' Cash from Financing Activities stood at -$341.0 million in 2022, then surged by 41.06% to -$201.0 million in 2023, then jumped by 112.44% to $25.0 million in 2024, then plunged by 900.0% to -$200.0 million in 2025, then grew by 28.0% to -$144.0 million in 2026.
  • Business Quant data shows A's Cash from Financing Activities at -$144.0 million in Q2 2026, -$222.0 million in Q1 2026, and -$200.0 million in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Thermo Fisher Scientific 234.15 Bn 230.09 Bn 8.34 Bn -1.57 Bn
2 Danaher 152.10 Bn 147.75 Bn 3.61 Bn 7.27 Bn
3 Natera 48.48 Bn 47.38 Bn 486.15 Mn 12.21 Mn
4 Agilent Technologies 44.35 Bn 42.55 Bn 990.00 Mn -144.00 Mn
5 Iqvia Holdings 43.68 Bn 41.60 Bn 1.44 Bn -214.00 Mn
6 Idexx Laboratories 43.02 Bn 42.83 Bn 779.09 Mn -325.19 Mn
7 Illumina 34.39 Bn 33.22 Bn 770.00 Mn -129.00 Mn
8 Mettler Toledo International 28.29 Bn 28.24 Bn 650.22 Mn -317.75 Mn
9 Labcorp Holdings 27.51 Bn 27.37 Bn 1.11 Bn -919.90 Mn
10 Quest Diagnostics 27.10 Bn 26.47 Bn 1.03 Bn -229.00 Mn

Historic Data

Download Data
DateValue
Apr 30, 2026 -144.00 Mn
Apr 30, 2026 -144.00 Mn
Jan 31, 2026 -222.00 Mn
Jan 31, 2026 -222.00 Mn
Oct 31, 2025 -200.00 Mn
Oct 31, 2025 -200.00 Mn
Jul 31, 2025 -219.00 Mn
Jul 31, 2025 -219.00 Mn
Apr 30, 2025 -116.00 Mn
Apr 30, 2025 -116.00 Mn
Jan 31, 2025 -180.00 Mn
Jan 31, 2025 -180.00 Mn
Oct 31, 2024 25.00 Mn
Oct 31, 2024 25.00 Mn
Jul 31, 2024 -246.00 Mn
Jul 31, 2024 -246.00 Mn
Apr 30, 2024 -291.00 Mn
Apr 30, 2024 -291.00 Mn
Jan 31, 2024 -240.00 Mn
Jan 31, 2024 -240.00 Mn